Tipranavir in highly antiretroviral treatment-experienced patients: Results from a French prospective cohort.

MLA

Allavena, Clotilde, et al. “Tipranavir in Highly Antiretroviral Treatment-Experienced Patients: Results from a French Prospective Cohort.” Scandinavian Journal of Infectious Diseases, vol. 44, no. 1, Jan. 2012, pp. 37–43. EBSCOhost, https://doi.org/10.3109/00365548.2011.598870.

APA

Allavena, C., Flandre, P., Pugliese, P., Valantin, M.-A., Poizot-Martin, I., Cabié, A., Melliez, H., Cuzin, L., Duvivier, C., Dellamonica, P., & Raffi, F. (2012). Tipranavir in highly antiretroviral treatment-experienced patients: Results from a French prospective cohort. Scandinavian Journal of Infectious Diseases, 44(1), 37–43. https://doi.org/10.3109/00365548.2011.598870

Chicago

Allavena, Clotilde, Philippe Flandre, Pascal Pugliese, Marc-Antoine Valantin, Isabelle Poizot-Martin, André Cabié, Hugues Melliez, et al. 2012. “Tipranavir in Highly Antiretroviral Treatment-Experienced Patients: Results from a French Prospective Cohort.” Scandinavian Journal of Infectious Diseases 44 (1): 37–43. doi:10.3109/00365548.2011.598870.